Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients with Sickle Cell Disease or Other Anemias

2020-07-04

عنوان الدراسة

دواء الدراسة

Deferiprone

رقم بروتوكول الدراسة

LA38-EXT

حالة الدراسة

Ongoing

موقع الدراسة

Aseer Central Hospital

مرحلة الدراسة

沙特阿拉伯王国政府所属的官方政府网站。

沙特官方政府网站的域名以下列后缀结尾 gov.sa

政府网站使用以下协议。 HTTPS 用于加密和安全。

在数字政府管理局注册,编号:

建议

<p style="text-align: justify;">Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of<br />Transfusional Iron Overload in Patients with Sickle Cell Disease<br />or Other Anemias</p>

<p style="text-align: justify;">Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of<br />Transfusional Iron Overload in Patients with Sickle Cell Disease<br />or Other Anemias</p>

沙特阿拉伯王国政府所属的官方政府网站。

沙特官方政府网站的域名以下列后缀结尾 gov.sa

政府网站使用以下协议。 HTTPS 用于加密和安全。

在数字政府管理局注册,编号:

<p style="text-align: justify;">Long-term Safety and Efficacy Study of Ferriprox&reg; for the Treatment of<br />Transfusional Iron Overload in Patients with Sickle Cell Disease<br />or Other Anemias</p>

<p style="text-align: justify;">Long-term Safety and Efficacy Study of Ferriprox&reg; for the Treatment of<br />Transfusional Iron Overload in Patients with Sickle Cell Disease<br />or Other Anemias</p>

<p style="text-align: justify;">Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of<br />Transfusional Iron Overload in Patients with Sickle Cell Disease<br />or Other Anemias</p>

<p style="text-align: justify;">Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of<br />Transfusional Iron Overload in Patients with Sickle Cell Disease<br />or Other Anemias</p>